Mirna L.M. Rodriguez

Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer

Matt I. Gross, Susan D. Demo, Jennifer B. Dennison et al. · Molecular Cancer Therapeutics · 2014 · 1.1K citations

Medicine, Oncology, Pharmacology +16

Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment

Susanne Steggerda, Mark K. Bennett, Jason Chen et al. · Journal for ImmunoTherapy of Cancer · 2017 · 444 citations · Full text

Medicine, Immunology, Oncology +17

LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in <i>KRAS</i> -Mutant Lung Adenocarcinoma

Ana Galán‐Cobo, Piyada Sitthideatphaiboon, Xiao Qu et al. · Cancer Research · 2019 · 274 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Targeted Inhibition of EGFR and Glutaminase Induces Metabolic Crisis in EGFR Mutant Lung Cancer

Milica Momcilovic, Sean T. Bailey, Jason T. Lee et al. · Cell Reports · 2017 · 165 citations · Full text

Medicine, Oncology, Pharmacology +17

Antitumor Activity Of The Glutaminase Inhibitor CB-839 In Hematological Malignances

Francesco Parlati, Shoshana Bromley-Dulfano, Susan D. Demo et al. · Blood · 2013 · 33 citations

Medicine, Oncology, Pharmacology +10